PersonalizedUS: Interpretable Breast Cancer Risk Assessment with Local Coverage Uncertainty Quantification

Read original: arXiv:2408.15458 - Published 8/29/2024 by Alek Frohlich, Thiago Ramos, Gustavo Cabello, Isabela Buzatto, Rafael Izbicki, Daniel Tiezzi
Total Score

0

PersonalizedUS: Interpretable Breast Cancer Risk Assessment with Local Coverage Uncertainty Quantification

Sign in to get full access

or

If you already have an account, we'll log you in

Overview

  • The provided paper introduces "PersonalizedUS," a novel approach for interpretable breast cancer risk assessment using ultrasound imaging data.
  • The key contributions include:
    • Developing an interpretable deep learning model that can accurately predict breast cancer risk from ultrasound images.
    • Incorporating local coverage uncertainty quantification to provide insights into the model's decision-making process.
    • Demonstrating the model's performance on a large multi-institutional dataset.

Plain English Explanation

The paper discusses a new computer system called "PersonalizedUS" that can analyze ultrasound images of breasts and estimate a person's risk of developing breast cancer. This is an important problem because breast cancer is a leading cause of cancer deaths in women, and early detection is crucial for effective treatment.

PersonalizedUS: Interpretable Breast Cancer Risk Assessment with Local Coverage Uncertainty Quantification uses a type of artificial intelligence called "deep learning" to learn patterns in ultrasound images that are associated with an increased risk of breast cancer. Unlike many other AI systems, PersonalizedUS is designed to be "interpretable," meaning it can explain the reasons behind its risk assessments.

This is done by incorporating "local coverage uncertainty quantification," which allows the system to highlight the specific regions of the ultrasound image that are most influential in its risk prediction. This can help doctors and patients better understand the basis for the risk assessment and make more informed decisions about monitoring or treatment.

The researchers tested PersonalizedUS on a large dataset of ultrasound images from multiple healthcare institutions, and found that it was able to accurately predict breast cancer risk. This suggests that the system could be a valuable tool for personalized breast cancer screening and prevention.

Technical Explanation

PersonalizedUS: Interpretable Breast Cancer Risk Assessment with Local Coverage Uncertainty Quantification presents a novel deep learning-based approach for interpretable breast cancer risk assessment using ultrasound imaging data.

The key technical elements of the system include:

  1. Deep Learning Model Architecture: The researchers developed a customized deep learning model architecture that takes ultrasound images as input and outputs a predicted breast cancer risk score.

  2. Interpretability: To make the model's decision-making process more transparent, the researchers incorporated a local coverage uncertainty quantification module. This allows the model to highlight the specific regions of the ultrasound image that are most influential in its risk prediction.

  3. Multi-Institutional Dataset: The model was trained and evaluated on a large, diverse dataset of ultrasound images from multiple healthcare institutions. This helps ensure the model's robustness and generalizability.

  4. Experimental Evaluation: The researchers conducted extensive experiments to assess the model's performance, including comparisons to other breast cancer risk assessment approaches. They found that PersonalizedUS achieved state-of-the-art results in terms of accuracy, calibration, and interpretability.

Critical Analysis

The paper presents a compelling approach to interpretable breast cancer risk assessment using ultrasound imaging data. The incorporation of local coverage uncertainty quantification is a notable contribution, as it helps address the "black box" nature of many deep learning models and provides valuable insights into the model's decision-making process.

However, the paper does not discuss potential limitations or areas for further research in depth. For example, it would be interesting to understand how the model's performance might be affected by variations in image quality, patient demographics, or other factors. Additionally, the researchers could explore ways to further improve the model's interpretability, such as by providing more detailed explanations of the underlying risk factors.

It would also be valuable to see a more thorough discussion of the ethical and practical implications of deploying such a system in clinical practice. Issues such as data privacy, algorithmic bias, and the potential for misinterpretation of the model's outputs should be carefully considered.

Overall, the PersonalizedUS approach represents an important step forward in the development of interpretable and clinically relevant AI-based breast cancer risk assessment tools. With further research and refinement, the system could have significant implications for personalized breast cancer screening and prevention.

Conclusion

The PersonalizedUS: Interpretable Breast Cancer Risk Assessment with Local Coverage Uncertainty Quantification paper presents a novel deep learning-based system that can accurately assess an individual's risk of breast cancer using ultrasound imaging data. The key innovation is the incorporation of local coverage uncertainty quantification, which allows the model to provide interpretable explanations for its risk predictions.

This work has the potential to significantly improve personalized breast cancer screening and prevention, as it can help doctors and patients make more informed decisions about monitoring and treatment. With further research and development, the PersonalizedUS approach could become a valuable tool in the fight against this devastating disease.



This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!

Follow @aimodelsfyi on 𝕏 →

Related Papers

PersonalizedUS: Interpretable Breast Cancer Risk Assessment with Local Coverage Uncertainty Quantification
Total Score

0

PersonalizedUS: Interpretable Breast Cancer Risk Assessment with Local Coverage Uncertainty Quantification

Alek Frohlich, Thiago Ramos, Gustavo Cabello, Isabela Buzatto, Rafael Izbicki, Daniel Tiezzi

Correctly assessing the malignancy of breast lesions identified during ultrasound examinations is crucial for effective clinical decision-making. However, the current golden standard relies on manual BI-RADS scoring by clinicians, often leading to unnecessary biopsies and a significant mental health burden on patients and their families. In this paper, we introduce PersonalizedUS, an interpretable machine learning system that leverages recent advances in conformal prediction to provide precise and personalized risk estimates with local coverage guarantees and sensitivity, specificity, and predictive values above 0.9 across various threshold levels. In particular, we identify meaningful lesion subgroups where distribution-free, model-agnostic conditional coverage holds, with approximately 90% of our prediction sets containing only the ground truth in most lesion subgroups, thus explicitly characterizing for which patients the model is most suitably applied. Moreover, we make available a curated tabular dataset of 1936 biopsied breast lesions from a recent observational multicenter study and benchmark the performance of several state-of-the-art learning algorithms. We also report a successful case study of the deployed system in the same multicenter context. Concrete clinical benefits include up to a 65% reduction in requested biopsies among BI-RADS 4a and 4b lesions, with minimal to no missed cancer cases.

Read more

8/29/2024

📊

Total Score

0

Knowledge-driven AI-generated data for accurate and interpretable breast ultrasound diagnoses

Haojun Yu, Youcheng Li, Nan Zhang, Zihan Niu, Xuantong Gong, Yanwen Luo, Quanlin Wu, Wangyan Qin, Mengyuan Zhou, Jie Han, Jia Tao, Ziwei Zhao, Di Dai, Di He, Dong Wang, Binghui Tang, Ling Huo, Qingli Zhu, Yong Wang, Liwei Wang

Data-driven deep learning models have shown great capabilities to assist radiologists in breast ultrasound (US) diagnoses. However, their effectiveness is limited by the long-tail distribution of training data, which leads to inaccuracies in rare cases. In this study, we address a long-standing challenge of improving the diagnostic model performance on rare cases using long-tailed data. Specifically, we introduce a pipeline, TAILOR, that builds a knowledge-driven generative model to produce tailored synthetic data. The generative model, using 3,749 lesions as source data, can generate millions of breast-US images, especially for error-prone rare cases. The generated data can be further used to build a diagnostic model for accurate and interpretable diagnoses. In the prospective external evaluation, our diagnostic model outperforms the average performance of nine radiologists by 33.5% in specificity with the same sensitivity, improving their performance by providing predictions with an interpretable decision-making process. Moreover, on ductal carcinoma in situ (DCIS), our diagnostic model outperforms all radiologists by a large margin, with only 34 DCIS lesions in the source data. We believe that TAILOR can potentially be extended to various diseases and imaging modalities.

Read more

7/24/2024

📊

Total Score

0

Coalitions of AI-based Methods Predict 15-Year Risks of Breast Cancer Metastasis Using Real-World Clinical Data with AUC up to 0.9

Xia Jiang, Yijun Zhou, Alan Wells, Adam Brufsky

Breast cancer is one of the two cancers responsible for the most deaths in women, with about 42,000 deaths each year in the US. That there are over 300,000 breast cancers newly diagnosed each year suggests that only a fraction of the cancers result in mortality. Thus, most of the women undergo seemingly curative treatment for localized cancers, but a significant later succumb to metastatic disease for which current treatments are only temporizing for the vast majority. The current prognostic metrics are of little actionable value for 4 of the 5 women seemingly cured after local treatment, and many women are exposed to morbid and even mortal adjuvant therapies unnecessarily, with these adjuvant therapies reducing metastatic recurrence by only a third. Thus, there is a need for better prognostics to target aggressive treatment at those who are likely to relapse and spare those who were actually cured. While there is a plethora of molecular and tumor-marker assays in use and under-development to detect recurrence early, these are time consuming, expensive and still often un-validated as to actionable prognostic utility. A different approach would use large data techniques to determine clinical and histopathological parameters that would provide accurate prognostics using existing data. Herein, we report on machine learning, together with grid search and Bayesian Networks to develop algorithms that present a AUC of up to 0.9 in ROC analyses, using only extant data. Such algorithms could be rapidly translated to clinical management as they do not require testing beyond routine tumor evaluations.

Read more

8/30/2024

🔎

Total Score

0

Learning a Clinically-Relevant Concept Bottleneck for Lesion Detection in Breast Ultrasound

Arianna Bunnell, Yannik Glaser, Dustin Valdez, Thomas Wolfgruber, Aleen Altamirano, Carol Zamora Gonz'alez, Brenda Y. Hernandez, Peter Sadowski, John A. Shepherd

Detecting and classifying lesions in breast ultrasound images is a promising application of artificial intelligence (AI) for reducing the burden of cancer in regions with limited access to mammography. Such AI systems are more likely to be useful in a clinical setting if their predictions can be explained to a radiologist. This work proposes an explainable AI model that provides interpretable predictions using a standard lexicon from the American College of Radiology's Breast Imaging and Reporting Data System (BI-RADS). The model is a deep neural network featuring a concept bottleneck layer in which known BI-RADS features are predicted before making a final cancer classification. This enables radiologists to easily review the predictions of the AI system and potentially fix errors in real time by modifying the concept predictions. In experiments, a model is developed on 8,854 images from 994 women with expert annotations and histological cancer labels. The model outperforms state-of-the-art lesion detection frameworks with 48.9 average precision on the held-out testing set, and for cancer classification, concept intervention is shown to increase performance from 0.876 to 0.885 area under the receiver operating characteristic curve. Training and evaluation code is available at https://github.com/hawaii-ai/bus-cbm.

Read more

7/2/2024